Proteoglycans and Their Role in Wound Repair

Proteoglycans are a heterogeneous group of protein-carbohydrate complexes that are distinguished from all other macromolecules by bearing glycosaminoglycan (GAG) chains. These linear polysaccharide chains are highly polyanionic (due to sulfate and carboxylate residues), bear the highest charge density of any vertebrate macro-molecule, and usually occupy a high proportion of the mass of the proteoglycans. The distinction is important because these properties differ from all other molecules in vertebrate tissues. Because of their chemical stability, the GAG chains have been known and well characterized for many years. Only relatively recently, with the identification of a large number of proteoglycan core proteins, have their roles in cellular behavior become apparent. The GAG chains play a primordial role in metazoans; they are produced by the simplest organisms and are synthesized very early during vertebrate development and by virtually every nucleated cell. While they have multiple potential functions, the explicit role of each GAG type depends both on its nature and on the core protein moiety to which the GAG chain is linked in a proteoglycan.

[1]  J. Forrester,et al.  Effect of hyaluronic acid on neutrophil adhesion. , 1981, Journal of cell science.

[2]  A. Bassols,et al.  Transforming growth factor beta regulates the expression and structure of extracellular matrix chondroitin/dermatan sulfate proteoglycans. , 1988, The Journal of biological chemistry.

[3]  A. Rapraeger Transforming growth factor (type beta) promotes the addition of chondroitin sulfate chains to the cell surface proteoglycan (syndecan) of mouse mammary epithelia , 1989, The Journal of cell biology.

[4]  M. Petitou,et al.  Structure-activity relationship in heparin: a synthetic pentasaccharide with high affinity for antithrombin III and eliciting high anti-factor Xa activity. , 1983, Biochemical and biophysical research communications.

[5]  K. Austen,et al.  Recent advances in the cellular and molecular biology of mast cells. , 1989, Immunology today.

[6]  A. Linker,et al.  Structure of the antithrombin-binding site in heparin. , 1979, Proceedings of the National Academy of Sciences of the United States of America.

[7]  M. Jalkanen,et al.  Cell surface proteoglycan associates with the cytoskeleton at the basolateral cell surface of mouse mammary epithelial cells , 1986, The Journal of cell biology.

[8]  P. Knox,et al.  Cell adhesion and proteoglycans. I. The effect of exogenous proteoglycans on the attachment of chick embryo fibroblasts to tissue culture plastic and collagen. , 1979, Journal of cell science.

[9]  K. Nordling,et al.  Extension and structural variability of the antithrombin-binding sequence in heparin. , 1984, The Journal of biological chemistry.

[10]  E. Engvall,et al.  Complexing of fibronectin glycosaminoglycans and collagen. , 1980, Biochimica et biophysica acta.

[11]  J. Forrester,et al.  Inhibition of leukocyte locomotion by hyaluronic acid. , 1981, Journal of cell science.

[12]  U Lindahl,et al.  Further characterization of the antithrombin-binding sequence in heparin. , 1982, Carbohydrate research.

[13]  U. Lindahl,et al.  Evidence for a 3-O-sulfated D-glucosamine residue in the antithrombin-binding sequence of heparin. , 1980, Proceedings of the National Academy of Sciences of the United States of America.

[14]  G. Weissmann,et al.  Cartilage proteoglycans inhibit fibronectin-mediated adhesion , 1981, Nature.

[15]  L. Harker,et al.  Measurements of Platelet Function , 1984 .

[16]  E. Ruoslahti,et al.  Effect of a proteoglycan produced by rat tumor cells on their adhesion to fibronectin-collagen substrata. , 1983, Cancer research.

[17]  K. N. Udupa,et al.  Chemical and histochemical sequences in the normal healing of wounds. , 1955, The New England journal of medicine.

[18]  E. Ruoslahti,et al.  Multiple domains of the large fibroblast proteoglycan, versican. , 1989, The EMBO journal.

[19]  R. Sanderson,et al.  B lymphocytes express and lose syndecan at specific stages of differentiation. , 1989, Cell regulation.

[20]  M. Karnovsky,et al.  Inhibition of vascular smooth muscle cell growth by endothelial cell-derived heparin. Possible role of a platelet endoglycosidase. , 1982, The Journal of biological chemistry.

[21]  Å. Danielsson,et al.  Role of ternary complexes, in which heparin binds both antithrombin and proteinase, in the acceleration of the reactions between antithrombin and thrombin or factor Xa. , 1986, The Journal of biological chemistry.

[22]  M. Petitou,et al.  Conformational flexibility: a new concept for explaining binding and biological properties of iduronic acid-containing glycosaminoglycans. , 1988, Trends in biochemical sciences.

[23]  P. Prehm Synthesis of hyaluronate in differentiated teratocarcinoma cells. Mechanism of chain growth. , 1983, The Biochemical journal.

[24]  J. Marcum,et al.  Anticoagulantly active heparin-like molecules from vascular tissue. , 1984, Biochemistry.

[25]  A. Sommer,et al.  Recombinant basic fibroblast growth factor accelerates wound healing. , 1988, The Journal of surgical research.

[26]  D Heinegård,et al.  Structure and biology of cartilage and bone matrix noncollagenous macromolecules , 1989, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[27]  D. Evered,et al.  The biology of hyaluronan. , 1989, Ciba Foundation symposium.